2020 UEM Edgenta Annual Report

17. INVESTMENT IN ASSOCIATES (CONTD.) ii. Summarised statements of comprehensive income Faber Sindoori Biomedix One Medicare Sedafiat Total RM’000 2020 2019 2020 2019 2020 2019 2020 2019 2020 2019 Revenue 100,023 107,604 61,066 52,130 204,506 196,597 246,200 243,000 611,795 599,331 Profit before tax 13,147 16,075 20,218 18,968 462 6,371 19,415 22,188 53,242 63,602 Profit/(loss) for the year 9,712 11,570 15,510 14,584 (110) 5,138 14,104 16,822 39,216 48,114 Total comprehensive income/(loss) 9,730 11,484 15,510 14,584 (110) 5,138 14,104 16,822 39,234 48,028 Dividend received from the associates during the year 748 986 4,160 2,400 800 1,200 2,000 1,200 7,708 5,786 iii. Reconciliation of the summarised financial information presented above to the carrying amount of the Group’s interest in associates Faber Sindoori Biomedix One Medicare Sedafiat Total RM’000 2020 2019 2020 2019 2020 2019 2020 2019 2020 2019 Net assets at 1 January 55,354 45,801 35,490 26,906 32,229 30,091 46,485 32,663 169,558 135,461 Total comprehensive income/(loss) 9,730 11,484 15,510 14,584 (110) 5,138 14,104 16,822 39,234 48,028 Dividend from associate (1,466) (1,931) (10,400) (6,000) (2,000) (3,000) (5,000) (3,000) (18,866) (13,931) Net assets at 31 December 63,618 55,354 40,600 35,490 30,119 32,229 55,589 46,485 189,926 169,558 Interest in associates 51% 51% 40% 40% 40% 40% 40% 40% Exchange differences (863) (863) – – – – – – (863) (863) Carrying value of Group’s interest in material associate 31,582 27,368 16,240 14,196 12,048 12,892 22,236 18,594 82,106 73,050 UEM EDGENTA BERHAD 252 Financial Statements NOTES TO THE FINANCIAL STATEMENTS For the year ended 31 December 2020